Cambridge, United States
Quiver Bioscience is a pioneering biotechnology company founded in 2013 with a mission encapsulated by their slogan: "Decoding Brain Disease to Reimagine Drug Development." The company is at the forefront of developing transformational medicines for brain disorders, leveraging cutting-edge technologies.
Quiver's innovation lies in its creation of the "Genomic Positioning System," the world's most comprehensive neuronal insight map, constructed using advanced single cell imaging, multi-omics, and proprietary AI/ML approaches. This technology enables the discovery of new biology and effective drug targets, potentially revolutionizing drug development for neurological diseases.
Recently, Quiver secured a $1.99M grant investment from the National Institute of Neurological Disorders and Stroke, highlighting investor confidence in their novel approach and promising solutions. This signals robust momentum in their quest to advance understanding and treatment of brain diseases.
Biofidelity